Hangzhou Hotide Biotech

Peptide products and custom synthesis company in Hangzhou Qiantang District serving pharma, biotech, and academic institutions. Solid-phase synthesis to 150 amino acids plus solution-phase platforms covering glycopeptides, cyclic peptides, PEGylated and fluorescently labeled peptides. Catalog, custom, and drug peptides including BPC-157 and linaclotide. Holds 2 active US DMFs for tirzepatide (2025).

Directory assessment: Hangzhou Hotide Biotech is listed as a CDMO in the peptide supply chain, serving Asia markets from China (Hangzhou). As a direct manufacturer, this supplier controls its own production process from synthesis through purification and quality control release testing. This profile lists 2 sources for reference. This supplier has a medium confidence score — verification signals are present, but the listing is newer or less documented; perform standard due diligence before engaging.